Coulter Partners secures Chief Scientific Officer for Biomia

Biomia is a preclinical biotech company that uses synthetic biology, biomanufacturing, and AI to discover and optimize nature-inspired medicines. The Company develops novel treatments for CNS disorders like cognitive deficits in mental health, neurodegenerative disorders, and post-surgical pain.

Dr. Westhorpe brings extensive experience orchestrating portfolio growth strategies across various neurological indications in both startup and mid-sized biotech companies. He's an expert in small molecule pharmacology, lead optimization, and preclinical drug development, with a proven track record of driving CNS research and preparing psychiatry drug discovery programs for clinical trials. Before joining Biomia, Dr. Westhorpe was Director of Discovery Pharmacology at Compass Pathways (UK), and he has also held senior leadership positions at Merck Research Labs (US) and CuraSen Therapeutics (US), focusing on in vitro sciences and pharmacology.

Commenting on the appointment, Michael Krogh Jensen, Ph.D., Biomia’s Co-Founder and Chief Executive Officer said: “We are excited to welcome Frederick to Biomia, and confident that his extensive small molecule drug discovery and development expertise will complement the team and guide our company’s next phase of strategic growth.

“Frederick’s almost-decade long experience in preclinical drug development, and specifically his recognized leadership in progressing CNS small molecule R&D programs to clinical readiness across a variety of CNS indications, will strengthen our capabilities as we advance our pipeline of small molecule therapeutic candidates towards the clinic”, Dr. Krogh continued.

Dr. Krogh also added: “We are incredibly pleased with the partnership we've had with Coulter Partners throughout this critical search. Their deep understanding of the life sciences landscape and their commitment to finding the perfect fit were instrumental in bringing a leader of Frederick Westhorpe's caliber to Biomia. This successful placement underscores the value of true collaboration in building a world-class scientific team.”

----

Frederick Westhorpe, PhD, Chief Scientific Officer of Biomia

About Biomia

About Coulter Partners